Category: Reagents

Filter By
Categories: RNA Categories: Small Molecules Clear all
(Boc-Cys-OH)2 (Boc-Cys-OH)2

(Boc-Cys-OH)2

Reference: CDX-B0224-G025
€0.00 (tax incl.)
Amino acid protected by tert-butoxycarbonyl (Boc) group. Used as a reactant in peptide synthesis. Used to obtain asymmetric cystine peptides by enzymatic catalysis with immobilized papain. Used as educt for obtaining...
(Boc-Cys-OH)2 (Boc-Cys-OH)2

(Boc-Cys-OH)2

Reference: CDX-B0224-G005
€0.00 (tax incl.)
Amino acid protected by tert-butoxycarbonyl (Boc) group. Used as a reactant in peptide synthesis. Used to obtain asymmetric cystine peptides by enzymatic catalysis with immobilized papain. Used as educt for obtaining...
(D)-(+)-Neopterin (D)-(+)-Neopterin

(D)-(+)-Neopterin

Reference: B7695-10
€0.00 (tax incl.)
Precursor of biopterin synthesis
(E)-8-Methyl-6-nonenoic acid (E)-8-Methyl-6-nonenoic acid

(E)-8-Methyl-6-nonenoic acid

Reference: CDX-M0209-G001
€0.00 (tax incl.)
Intermediate of the capsaicin biosynthesis. Fatty acid derivative from leucine/valine pathway. Plays a crucial role in determining the efficacy of capsaicin levels. The quantity of (E)-8-Methyl-6-nonenoic acid...
(E)-8-Methyl-6-nonenoic acid (E)-8-Methyl-6-nonenoic acid

(E)-8-Methyl-6-nonenoic acid

Reference: CDX-M0209-M500
€0.00 (tax incl.)
Intermediate of the capsaicin biosynthesis. Fatty acid derivative from leucine/valine pathway. Plays a crucial role in determining the efficacy of capsaicin levels. The quantity of (E)-8-Methyl-6-nonenoic acid...
(R)-(+)-2-Phenyl-1-propanol (R)-(+)-2-Phenyl-1-propanol

(R)-(+)-2-Phenyl-1-propanol

Reference: CDX-P0385-G001
€0.00 (tax incl.)
Important building block and synthetic intermediate reagent for synthesis of chiral compounds.
(R)-(+)-Atenolol (R)-(+)-Atenolol

(R)-(+)-Atenolol

Reference: C3031-25
€0.00 (tax incl.)
less active enantiomer of the racemic β1-adrenergic receptor antagonist, (R,S)-atenolol.
(R)-(+)-Atenolol (R)-(+)-Atenolol

(R)-(+)-Atenolol

Reference: C3031-10
€0.00 (tax incl.)
less active enantiomer of the racemic β1-adrenergic receptor antagonist, (R,S)-atenolol.
(R)-(+)-Atenolol (R)-(+)-Atenolol

(R)-(+)-Atenolol

Reference: C3031-5
€0.00 (tax incl.)
less active enantiomer of the racemic β1-adrenergic receptor antagonist, (R,S)-atenolol.
(R)-(+)-Blebbistatin (R)-(+)-Blebbistatin

(R)-(+)-Blebbistatin

Reference: B6877-1
€0.00 (tax incl.)
non-muscle myosin II ATPases inhibitor, cell-permeable
(R)-(+)-HA-966 (R)-(+)-HA-966

(R)-(+)-HA-966

Reference: B6243-10
€0.00 (tax incl.)
NMDA receptor antagonist/partial agonist
(R)-3,4-DCPG (R)-3,4-DCPG

(R)-3,4-DCPG

Reference: B6719-50
€0.00 (tax incl.)
AMPA receptor antagonist with weak activity at NMDA receptors and little activity at kainate receptors
(R)-3,4-DCPG (R)-3,4-DCPG

(R)-3,4-DCPG

Reference: B6719-10
€0.00 (tax incl.)
AMPA receptor antagonist with weak activity at NMDA receptors and little activity at kainate receptors
(R)-3-Hydroxybutyric acid (R)-3-Hydroxybutyric acid

(R)-3-Hydroxybutyric acid

Reference: AG-CR1-3616-M100
€0.00 (tax incl.)
Key metabolite of the ketolytic pathway generating acetyl-CoA. Stereoselective product of D-3-hydroxybutyrate dehydreogenase. Clinically and physiologically significant stereoisomer. Energy carrier from adipocytes to...
(R)-3-Hydroxybutyric acid (R)-3-Hydroxybutyric acid

(R)-3-Hydroxybutyric acid

Reference: AG-CR1-3616-M025
€0.00 (tax incl.)
Key metabolite of the ketolytic pathway generating acetyl-CoA. Stereoselective product of D-3-hydroxybutyrate dehydreogenase. Clinically and physiologically significant stereoisomer. Energy carrier from adipocytes to...
(R)-3-Hydroxymyristic acid (R)-3-Hydroxymyristic acid

(R)-3-Hydroxymyristic acid

Reference: CDX-H0114-G001
€0.00 (tax incl.)
Hydroxy fatty acid used to study its role in biological processes such as oxidative stress, inflammation and insulin resistance. Used in endotoxin and lipid A research, since it is one of two major components of...
(R)-3-Hydroxymyristic acid (R)-3-Hydroxymyristic acid

(R)-3-Hydroxymyristic acid

Reference: CDX-H0114-M250
€0.00 (tax incl.)
Hydroxy fatty acid used to study its role in biological processes such as oxidative stress, inflammation and insulin resistance. Used in endotoxin and lipid A research, since it is one of two major components of...
(R)-AMPA (R)-AMPA

(R)-AMPA

Reference: B6237-10
€0.00 (tax incl.)
inactive enantiomer of AMPA
(R)-baclofen (R)-baclofen

(R)-baclofen

Reference: B1531-50
€0.00 (tax incl.)
GABA receptor agonist
(R)-baclofen (R)-baclofen

(R)-baclofen

Reference: B1531-10
€0.00 (tax incl.)
GABA receptor agonist
(R)-BI-2536 (R)-BI-2536

(R)-BI-2536

Reference: SYN-1019-M100
€0.00 (tax incl.)
Polo-like kinase 1 (Plk1) is a regulator of the cell cycle that has been implicated in the pathology of many cancers. BI-2536 is a potent and selective small-molecule inhibitor of mammalian Plk1. It has inhibitory...
(R)-BI-2536 (R)-BI-2536

(R)-BI-2536

Reference: SYN-1019-M050
€0.00 (tax incl.)
Polo-like kinase 1 (Plk1) is a regulator of the cell cycle that has been implicated in the pathology of many cancers. BI-2536 is a potent and selective small-molecule inhibitor of mammalian Plk1. It has inhibitory...
(R)-BI-2536 (R)-BI-2536

(R)-BI-2536

Reference: SYN-1019-M010
€0.00 (tax incl.)
Polo-like kinase 1 (Plk1) is a regulator of the cell cycle that has been implicated in the pathology of many cancers. BI-2536 is a potent and selective small-molecule inhibitor of mammalian Plk1. It has inhibitory...
(R)-BI-2536 (R)-BI-2536

(R)-BI-2536

Reference: SYN-1019-M005
€0.00 (tax incl.)
Polo-like kinase 1 (Plk1) is a regulator of the cell cycle that has been implicated in the pathology of many cancers. BI-2536 is a potent and selective small-molecule inhibitor of mammalian Plk1. It has inhibitory...
(R)-BI-2536 (R)-BI-2536

(R)-BI-2536

Reference: SYN-1019-M001
€0.00 (tax incl.)
Polo-like kinase 1 (Plk1) is a regulator of the cell cycle that has been implicated in the pathology of many cancers. BI-2536 is a potent and selective small-molecule inhibitor of mammalian Plk1. It has inhibitory...
(R)-CCG-1423 (R)-CCG-1423

(R)-CCG-1423

Reference: C5799-10
€0.00 (tax incl.)
Rho inhibitor
(R)-CCG-1423 (R)-CCG-1423

(R)-CCG-1423

Reference: C5799-5
€0.00 (tax incl.)
Rho inhibitor
(R)-CPP (R)-CPP

(R)-CPP

Reference: B6236-50
€0.00 (tax incl.)
NMDA antagonist
(R)-CPP (R)-CPP

(R)-CPP

Reference: B6236-10
€0.00 (tax incl.)
NMDA antagonist
(R)-CR8 (R)-CR8

(R)-CR8

Reference: AG-MR-C0003-M050
€0.00 (tax incl.)
Potent and selective inhibitor of cyclin dependent kinases CDK1, CDK2, CDK5, CDK7 and CDK9. Apoptosis inducer. Inhibits the proliferation of various cancer cell lines. Casein kinase 1 (CK1delta/epsilon) and glycogen...
(R)-CR8 (R)-CR8

(R)-CR8

Reference: AG-MR-C0003-M010
€0.00 (tax incl.)
Potent and selective inhibitor of cyclin dependent kinases CDK1, CDK2, CDK5, CDK7 and CDK9. Apoptosis inducer. Inhibits the proliferation of various cancer cell lines. Casein kinase 1 (CK1delta/epsilon) and glycogen...
(R)-CR8 (R)-CR8

(R)-CR8

Reference: AG-CR1-0039-M005
€0.00 (tax incl.)
Potent and selective cyclin-dependent kinase (CDK) 1, 2, 5, 7 and 9 inhibitor. Apoptosis inducer. Potent glycogen synthase kinase (GSK-3alpha/beta) inhibitor.
(R)-CR8 (R)-CR8

(R)-CR8

Reference: AG-CR1-0039-M001
€0.00 (tax incl.)
Potent and selective cyclin-dependent kinase (CDK) 1, 2, 5, 7 and 9 inhibitor. Apoptosis inducer. Potent glycogen synthase kinase (GSK-3alpha/beta) inhibitor.
(R)-Crizotinib (R)-Crizotinib

(R)-Crizotinib

Reference: A3020-100
€0.00 (tax incl.)
C-MET/ALK inhibitor,potent and ATP-competitve
(R)-Crizotinib (R)-Crizotinib

(R)-Crizotinib

Reference: A3020-50
€0.00 (tax incl.)
C-MET/ALK inhibitor,potent and ATP-competitve
(R)-Crizotinib (R)-Crizotinib

(R)-Crizotinib

Reference: A3020-5.1
€0.00 (tax incl.)
C-MET/ALK inhibitor,potent and ATP-competitve
(R)-Crizotinib (R)-Crizotinib

(R)-Crizotinib

Reference: A3020-10
€0.00 (tax incl.)
C-MET/ALK inhibitor,potent and ATP-competitve
(R)-DPN (R)-DPN

(R)-DPN

Reference: B7672-10
€0.00 (tax incl.)
estrogen receptor (ER) β agonist
(R)-FSL-1 (R)-FSL-1

(R)-FSL-1

Reference: AG-CP3-0010-C100
€0.00 (tax incl.)
R-FSL-1 (R-Pam2CGDPKHPKSF) is a synthetic lipoprotein that represents the N-terminal part of the 44kDa lipoprotein LP44 of Mycoplasma salivarium. The naturally occurring R-stereoisomer is biologically more active than...
(R)-Lisofylline (R)-Lisofylline

(R)-Lisofylline

Reference: C4158-10
€0.00 (tax incl.)
anti-inflammatory agent
(R)-Lisofylline (R)-Lisofylline

(R)-Lisofylline

Reference: C4158-5
€0.00 (tax incl.)
anti-inflammatory agent
(R)-Lisofylline (R)-Lisofylline

(R)-Lisofylline

Reference: C4158-1
€0.00 (tax incl.)
anti-inflammatory agent
(R)-Perharidine 1 (R)-Perharidine 1

(R)-Perharidine 1

Reference: AG-MR-C0013-M025
€0.00 (tax incl.)
Potent and selective inhibitor of cyclin dependent kinases CDK1, CDK2, CDK5 and CDK9. Apoptosis inducer. Inhibits the proliferation of various cancer cell lines. Casein kinase 1 (CK1delta/epsilon) inhibitor. Potential...
(R)-Perharidine 1 (R)-Perharidine 1

(R)-Perharidine 1

Reference: AG-MR-C0013-M005
€0.00 (tax incl.)
Potent and selective inhibitor of cyclin dependent kinases CDK1, CDK2, CDK5 and CDK9. Apoptosis inducer. Inhibits the proliferation of various cancer cell lines. Casein kinase 1 (CK1delta/epsilon) inhibitor. Potential...
(R)-Perharidine 1 (R)-Perharidine 1

(R)-Perharidine 1

Reference: AG-MR-C0013-M001
€0.00 (tax incl.)
Potent and selective inhibitor of cyclin dependent kinases CDK1, CDK2, CDK5 and CDK9. Apoptosis inducer. Inhibits the proliferation of various cancer cell lines. Casein kinase 1 (CK1delta/epsilon) inhibitor. Potential...
(R)-Roscovitine (R)-Roscovitine

(R)-Roscovitine

Reference: AG-MR-C0001-M025
€0.00 (tax incl.)
Potent and selective inhibitor of cyclin dependent kinases CDK1, CDK2, CDK5, CDK7 and CDK9. Pyridoxal kinase (PDXK) inhibitor. Triggers cell apoptotic cell death. Down-regulates Mcl-1 and MYCN. Anticancer compound....
(R)-Roscovitine (R)-Roscovitine

(R)-Roscovitine

Reference: AG-CR1-0006-M050
€0.00 (tax incl.)
Potent and selective inhibitor of CDKs. More potent than olomoucine. Inhibits CDK1/cyclin B kinase (IC50 = 450 nM), CDK2 (IC50 = 700 nM) and CDK5/p35 (IC50 = 160 nM). Inhibits M phase promoting factor (MPF) kinase...
(R)-Roscovitine (R)-Roscovitine

(R)-Roscovitine

Reference: AG-CR1-0006-M005
€0.00 (tax incl.)
Potent and selective inhibitor of CDKs. More potent than olomoucine. Inhibits CDK1/cyclin B kinase (IC50 = 450 nM), CDK2 (IC50 = 700 nM) and CDK5/p35 (IC50 = 160 nM). Inhibits M phase promoting factor (MPF) kinase...
(R)-Roscovitine (R)-Roscovitine

(R)-Roscovitine

Reference: AG-CR1-0006-M001
€0.00 (tax incl.)
Potent and selective inhibitor of CDKs. More potent than olomoucine. Inhibits CDK1/cyclin B kinase (IC50 = 450 nM), CDK2 (IC50 = 700 nM) and CDK5/p35 (IC50 = 160 nM). Inhibits M phase promoting factor (MPF) kinase...
(R)-SLV 319 (R)-SLV 319

(R)-SLV 319

Reference: C5122-50
€0.00 (tax incl.)
CB1 receptor antagonist
(R)-SLV 319 (R)-SLV 319

(R)-SLV 319

Reference: C5122-10
€0.00 (tax incl.)
CB1 receptor antagonist
(R)-SLV 319 (R)-SLV 319

(R)-SLV 319

Reference: C5122-5
€0.00 (tax incl.)
CB1 receptor antagonist
(R,R)-THC (R,R)-THC

(R,R)-THC

Reference: B6909-10
€0.00 (tax incl.)
agonist at ERα receptor and antagonist at ERβ receptor

Menu

Settings

Please sign in first.

Sign in